A carregar...
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
The pursuit of matrix metalloproteinase (MMP) inhibitors began in earnest over three decades ago. Initial clinical trials were disappointing, resulting in a negative view of MMPs as therapeutic targets. As a better understanding of MMP biology and inhibitor pharmacokinetic properties emerged, it bec...
Na minha lista:
| Publicado no: | Cells |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6769477/ https://ncbi.nlm.nih.gov/pubmed/31461880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells8090984 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|